pharmaphorum1d
ACC25: Mineralys' uncontrolled hypertension drug aces trial
That is the conclusion of the Advance-HTN study reported at the American College of Cardiology (ACC) meeting, which found ...
MPR1d
FDA Decision on Etripamil Nasal Spray Delayed Due to Nonclinical Issues
The Food and Drug Administration (FDA) has issued a Complete Response Letter to Milestone Pharmaceuticals regarding the New Drug Application (NDA) for ...
PharmiWeb13d
At a CAGR of 5.7%, Calcium Channel Blockers Market: Rising Demand for Cardiovascular Solutions & Drug Innovation Through 2035 - TMR Research
The Calcium Channel Blockers Market was valued at US$ 14.5 Bn in 2022 and is projected to grow at a CAGR of 5.7% from 2023 to ...
Hosted on MSN14d
9 Potential Side Effects of Calcium Channel Blockers You Should Watch For
President Trump signs order aimed at dismantling the Department of Education Tony Robbins delivers blunt message about annuities Accenture is DOGE's first corporate casualty as shares dive on ...
Knowridge Science Report3d
Could a common blood pressure medicine raise risk of vision loss?
A new study from the UK suggests that a widely used blood pressure medicine—Calcium Channel Blockers (CCBs)—may be linked to ...
MedPage Today9d
Different Post-CABG Meds May Help Radial Artery Graft Patency
In current European and American revascularization guidelines, RA grafts are now strongly endorsed as the second conduit for CABG based on easy harvesting and relative greater patency over time, among ...